For Investors
Know what you're buying. Improve what you own.
Novarra provides independent senior technology judgment for family capital, investment teams and private investors when technology is material to the investment case.
Investment lifecycle
Underwrite → Assure → Improve → Exit
One decision model connects pre-investment evidence to post-close priorities, recurring portfolio oversight and exit readiness.
01
Underwrite
Test technology, product, AI, cyber, data, vendors and leadership before capital is committed.
02
Assure
Maintain a consistent view of material technology risk, value creation and execution across the portfolio.
03
Improve
Translate findings into 100-day priorities, leadership support, architecture decisions and accountable action.
04
Exit
Strengthen evidence, remediate material gaps and prepare the technology story for buyer diligence.
When the work becomes material
Technology should enter the investment conversation when it can change the answer.
The scope follows the decision, not a generic checklist.
Before signing or funding
Technology can change valuation, deal structure, management commitments, capex assumptions or the decision to proceed.
During the first 100 days
Convert diligence findings into a realistic sequence of remediation, leadership and architecture decisions.
Across a portfolio
Create a consistent board-level view of where technology risk or value-creation potential needs attention.
Before exit
Reduce avoidable diligence friction and make the technology equity story supportable with evidence.
Primary entry offers
Start with the investment decision in front of you.
Specialist depth sits underneath the engagement and is introduced only where the evidence requires it.
Pre-investment
Deal Technology Due Diligence
Decision-ready technology diligence that connects technical evidence to investment implications and post-close priorities.
Ownership period
Portfolio Technology Assurance
A recurring senior technology-assurance layer for investors who need a consistent view across what they own.
What we examine
Enough technical depth to support the investment decision.
The exact scope is proportionate to the transaction, company and decision at hand.
What reaches the IC or board
Evidence should become a decision, not a larger technical report.
Decision-ready verdict
What is material, what is not, what remains uncertain and why it matters to the investment case.
Implications, not just findings
Translate technical evidence into business, valuation, capital, risk and execution implications.
Prioritised action
Specify what should happen now, in the first 100 days and through the ownership period.
Independent judgment
The diagnosis comes before the implementation.
Novarra is not tied to a software vendor, platform or large implementation programme. We may help execute where that is the right answer, but the advice does not depend on selling the implementation.